Adult neural stem cell therapy - Microbot Medical
Alternative Names: hCNS-SC; HuCNS-SC; HuCNS-SC cells; Neurodegenerative disorders stem cell therapy - Microbot MedicalLatest Information Update: 21 Apr 2021
Price :
$50 *
At a glance
- Originator StemCells
- Developer Microbot Medical; Oregon Health & Science University; StemCells; University of California at Irvine
- Class Neural stem cell therapies; Neuroprotectants
- Mechanism of Action Cell replacements; Myelin protein stimulants; Neurogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Alzheimer's disease; Retinal disorders
Highest Development Phases
- Discontinued Alzheimer's disease; Dry age-related macular degeneration; Neuronal ceroid lipofuscinosis; Pelizaeus-Merzbacher disease; Spinal cord injuries; Stroke
Most Recent Events
- 15 Apr 2021 Discontinued - Phase-I for Pelizaeus-Merzbacher disease in USA (Intracerebral)
- 15 Apr 2021 Discontinued - Phase-I/II for Spinal cord injuries in Switzerland (Intraosseous)
- 15 Apr 2021 Discontinued - Phase-II for Dry age-related macular degeneration in USA (Intraocular)